Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis. (Q43725536)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

title

Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Monireh Mohsenzadegan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

Zahra Madjd

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

Mojgan Asgari

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

Mehdi Shekarabi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

Jaleh Taeb

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

Ahmad Shariftabrizi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

1 reference

17 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

1609-1618

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Identification of PSA peptide mimotopes using phage display peptide library

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Target molecules in specific immunotherapy against prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Targeting novel antigens for prostate cancer treatment: focus on prostate-specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

NGEP, a gene encoding a membrane protein detected only in prostate cancer and normal prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

ANOs 3–7 in the anoctamin/Tmem16 Cl− channel family are intracellular proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Anoctamin/TMEM16 family members are Ca2 -activated Cl- channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Expression of genes encoding multi-transmembrane proteins in specific primate taste cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Topology of NGEP, a prostate-specific cell:cell junction protein widely expressed in many cancers of different grade level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Towards curative cancer immunotherapy: overcoming posttherapy tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Prostate cancer as a model for tumour immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Pox viral vaccine approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

The evolving role of immunotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Biochemical recurrence in Gleason score 7 prostate cancer in korean men: significance of the primary Gleason grade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Staging of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Immunotoxin treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Prostate-specific membrane antigen (PSMA) protein expression in normal and neoplastic tissues and its sensitivity and specificity in prostate adenocarcinoma: an immunohistochemical study using mutiple tumour tissue microarray technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-013-1463-1

10.1007/S00262-013-1463-1

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

7 March 2020

1003001576

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23955683 AND SRC:MED&resulttype=core&format=json